Global Anti-Asthma Short Acting Beta Agonists Market is projected...

adicionou um novo artigo Outro

2026-01-20 12:11:26 -

Global Anti-Asthma Short Acting Beta Agonists Market is projected to reach USD 1.785 billion by 2034

According to a newly published market research report by 24LifeSciences, Global Anti-Asthma Short Acting Beta Agonists market was valued at USD 1.37 billion in 2026 and is projected to reach USD 1.785 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.9% during the forecast period 2026-2034. Short-acting beta agonists (SABAs) are bronchodilators primarily used to...

0 Comentários 0 Compartilhamentos 40 Visualizações